Is higher dose always the right answer in stereotactic body radiation therapy for small hepatocellular carcinoma?
Kyung Hwa Lee, Jeong Il Yu, Hee Chul Park, Su Yeon Park, Jung Suk Shin, Eun Hyuk Shin, Sungkoo Cho, Sang Hoon Jung, Young Yih Han, Do Hoon Lim
Radiat Oncol J. 2018;36(2):129-138.   Published online 2018 Jun 29     DOI: https://doi.org/10.3857/roj.2017.00598
Citations to this article as recorded by Crossref logo
Optimal hypofractionated radiation therapy schemes for early-stage hepatocellular carcinoma
Feng Liu, Doris R. Brown, Michael T. Munley
Radiotherapy and Oncology.2024; 194: 110223.     CrossRef
Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
Myung Ji Goh, Hee Chul Park, Jeong Il Yu, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Dong Hyun Sinn, Moon Seok Choi
Liver Cancer.2023; 12(5): 467.     CrossRef
Hypofractionation in Hepatocellular Carcinoma – The Effect of Fractionation Size
S. Lewis, A. Barry, M.A. Hawkins
Clinical Oncology.2022; 34(5): e195.     CrossRef
Favorable response to multimodal treatment in hepatocellular carcinoma with inferior vena cava and right atrial tumor thrombus and left adrenal gland metastasis
Ning Sun, Jialin Zhang, Baifeng Li, Ailin Li, Mutian Lv, Chengshuo Zhang
Medicine.2021; 100(49): e27987.     CrossRef
Scores of Child–Pugh Classification Impact Overall Survival After Stereotactic Body Radiation Therapy for Primary and Metastatic Liver Tumors
Osamu Tanaka, Takao Kojima, Akihiro Ohbora, Chiyoko Makita, Takuya Taniguchi, Kousei Ono, Masayuki Matsuo, Yasushi Nagata
Journal of Clinical and Experimental Hepatology.2020; 10(2): 101.     CrossRef
A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy
Won Il Jang, Sun Hyun Bae, Mi‐Sook Kim, Chul Ju Han, Su Cheol Park, Sang Bum Kim, Eung‐Ho Cho, Chul Won Choi, Kyung Su Kim, Sangyoun Hwang, Jin Ho Kim, A Ram Chang, Younghee Park, Eun Seog Kim, Woo Chul Kim, Sunmi Jo, Hae Jin Park
Cancer.2020; 126(2): 363.     CrossRef
Clinical outcomes of stereotactic body radiation therapy for small hepatocellular carcinoma
Sunmin Park, Jinhong Jung, Byungchul Cho, So Yeon Kim, Sung‐Cheol Yun, Young‐Suk Lim, Han Chu Lee, Jongmoo Park, Jin‐hong Park, Jong Hoon Kim, Sang Min Yoon
Journal of Gastroenterology and Hepatology.2020; 35(11): 1953.     CrossRef
Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma
Gyu Sang Yoo, Jeong Il Yu, Sungkoo Cho, Sang Hoon Jung, Youngyih Han, Seyjoon Park, Yoonjin Oh, Boram Lee, Hee Chul Park, Do Hoon Lim, Moon Seok Choi, Hojeong Won
Radiotherapy and Oncology.2020; 146: 187.     CrossRef
RETRACTED ARTICLE: The PI3K/mTOR dual inhibitor BEZ235 nanoparticles improve radiosensitization of hepatoma cells through apoptosis and regulation DNA repair pathway
Xiaolong Tang, Amin Li, Chunmei Xie, Yinci Zhang, Xueke Liu, Yinghai Xie, Binquan Wu, Shuping Zhou, Xudong Huang, Yongfang Ma, Weiya Cao, Ruyue Xu, Jing Shen, Zhen Huo, Shuyu Cai, Yong Liang, Dong Ma
Nanoscale Research Letters.2020;[Epub]     CrossRef
Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
Tae Hyun Kim, Joong-Won Park, Bo Hyun Kim, Eun Sang Oh, Sang Hee Youn, Sung Ho Moon, Sang Soo Kim, Sang Myung Woo, Young-Hwan Koh, Woo Jin Lee, Dae Yong Kim
Frontiers in Oncology.2020;[Epub]     CrossRef
Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma
Jeong Il Yu, Hee Chul Park, Gyu Sang Yoo, Seung Woon Paik, Moon Seok Choi, Hye-Seung Kim, Insuk Sohn, Heerim Nam
Cancers.2020; 12(5): 1300.     CrossRef
Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter?
Gyu Sang Yoo, Jeong Il Yu, Hee Chul Park, Dongho Hyun, Woo Kyoung Jeong, Ho Yeong Lim, Moon Seok Choi, Sang Yun Ha
Cancers.2020; 12(9): 2395.     CrossRef
Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial
Sang Min Yoon, So Yeon Kim, Young-Suk Lim, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Jihyun An, Jinhong Jung, Jong Hoon Kim, Han Chu Lee
Clinical and Molecular Hepatology.2020; 26(4): 506.     CrossRef
Transarterial Chemoembolization Followed by Radiotherapy Versus Sandwich Treatment for Unresectable or Ablative Hepatocellular Carcinoma
Haimin Lin, Huiyong Wu, Ning Cong, Bo Liu, Chengxin Liu, Dali Han
Technology in Cancer Research & Treatment.2020; 19: 153303382098379.     CrossRef
Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
Changhoon Choi, Gyu Sang Yoo, Won Kyung Cho, Hee Chul Park
World Journal of Gastroenterology.2019; 25(20): 2416.     CrossRef
Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
Jongmoo Park, Jae Won Park, Min Kyu Kang
Yeungnam University Journal of Medicine.2019; 36(3): 192.     CrossRef
Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma
Jeong Il Yu, Su Jin Lee, Jeeyun Lee, Ho Yeong Lim, Seung Woon Paik, Gyu Sang Yoo, Changhoon Choi, Hee Chul Park
Cancer Medicine.2019; 8(16): 6986.     CrossRef